Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Inegy 10 mg/40 mg tablets PA23198/024/003 |
Ezetimibe, Simvastatin | Organon Pharma (Ireland) Limited | Marketed |
| Inegy 10 mg/80 mg Tablets PA23198/024/004 |
Ezetimibe, Simvastatin | Organon Pharma (Ireland) Limited | Marketed |
| Inegy 10mg/10mg Tablets PA23198/024/001 |
Ezetimibe, Simvastatin | Organon Pharma (Ireland) Limited | Not marketed |
| Infanrix hexa EU/1/00/152/001 |
Haemophilus influenzae, Pertussis toxoid, Tetanus toxoid, Polysaccharide-k, Diphtheria toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/002 |
Haemophilus influenzae, Hbs ag, Tetanus toxoid, Pertussis toxoid, Filamentous haemagglutinin | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/003 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/004 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/005 |
Pertactin, Pertussis toxoid, Hbs ag, Diphtheria toxoid, Filamentous haemagglutinin | GlaxoSmithKline Biologicals | — |
| Infanrix hexa EU/1/00/152/006 |
Filamentous haemagglutinin, Polysaccharide-k, Diphtheria toxoid, Haemophilus influenzae, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | Marketed |
| Infanrix hexa EU/1/00/152/007 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/008 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/009 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/010 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/011 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/012 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals | — |
| Infanrix hexa EU/1/00/152/013 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/014 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/015 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/016 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Inflectra 100 mg powder for concentrate for solution for infusion EU/1/13/854/001-005 |
Ct-p13 (infliximab) | Pfizer Europe MA EEIG | — |
| Influvac sub-unit, suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated) PA23355/031/001 |
A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238, Influenza virus B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26), Influenza A virus, A/Croatia/10136RV/2023 (H3N2) like strain X-425A, Inactivated | Viatris Healthcare Limited | Marketed |
| Influvac Tetra, suspension for injection in pre-filled syringe (influenza vaccine, surface antigen, inactivated) PA23355/016/001 |
A/Victoria/2570/2019 (H1N1)pdm09 - like strain (A/Victoria/2570/2019, IVR-215), B/PHUKET/3073/2013 -LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE), B/Austria/1359417/2021 - like strain (B/Michigan/01/2021, wild type), Influenza A virus, A/Croatia/10136RV/2023 (H3N2) like strain X-425A, Inactivated | Viatris Healthcare Limited | Not marketed |
| Infutraze concentrate for solution for infusion PA2059/083/001 |
Copper chloride dihydrate, Manganese chloride tetrahydrate, Potassium iodide, Sodium selenite anhydrous, Zinc chloride | Fresenius Kabi Deutschland GmbH | Not marketed |
| Inhixa 10,000 IU (100 mg)/1 mL solution for injection in pre-filled syringe EU/1/16/1132/009-010 |
Enoxaparin sodium | Techdow Pharma Netherlands B.V | — |
| Inhixa 12,000 IU (120 mg)/0.8 mL solution for injection in pre-filled syringe EU/1/16/1132/069 |
Enoxaparin sodium | Techdow Pharma Netherlands B.V | — |
| Inhixa 15,000 IU (150 mg)/1 mL solution for injection in pre-filled syringe EU/1/16/1132/070 |
Enoxaparin sodium | Techdow Pharma Netherlands B.V | — |
| Inhixa 2,000 IU (20 mg)/0.2 mL solution for injection in pre-filled syringe EU/1/16/1132/001-002 |
Enoxaparin sodium | Techdow Pharma Netherlands B.V | — |
| Inhixa 30,000 IU (300 mg)/3 mL solution for injection in multidose container EU/1/16/1132/071 |
Enoxaparin sodium, Enoxaparin sodium | Techdow Pharma Netherlands B.V | — |
| Inhixa 4,000 IU (40 mg)/0.4 mL solution for injection in pre-filled syringe EU/1/16/1132/003-004 |
Enoxaparin sodium | Techdow Pharma Netherlands B.V | — |
| Inhixa 50,000 IU (500 mg)/5 mL solution for injection in multidose container EU/1/16/1132/072 |
Enoxaparin sodium, Enoxaparin sodium | Techdow Pharma Netherlands B.V | — |
| Inhixa 6,000 IU (60 mg)/0.6 mL solution for injection in pre-filled syringe EU/1/16/1132/005-006 |
Enoxaparin sodium | Techdow Pharma Netherlands B.V | — |
| Inhixa 8,000 IU (80 mg)/0.8 mL solution for injection in pre-filled syringe EU/1/16/1132/007-008 |
Enoxaparin sodium | Techdow Pharma Netherlands B.V | — |
| Inlyta 3 mg film-coated tablets EU/1/12/777/007-009 |
Axitinib | Pfizer Europe MA EEIG | — |
| Inlyta 5 mg film-coated tablets EU/1/12/777/004-006 |
Axitinib | Pfizer Europe MA EEIG | — |
| Inlyta 7 mg film-coated tablets EU/1/12/777/010-012 |
Axitinib | Pfizer Europe MA EEIG | — |
| Inlyta1 mg film-coated tablets EU/1/12/777/001-003 |
Axitinib | Pfizer Europe MA EEIG | — |
| innohep 10,000 IU in 0.5 ml, solution for injection PPA0465/499/003 |
Tinzaparin sodium | PCO Manufacturing Ltd. | — |
| Innohep 10,000 IU in 0.5 ml, solution for injection PA0046/060/010 |
Tinzaparin sodium | Leo Laboratories Limited | Marketed |
| Innohep 10,000 IU in 0.5 ml, solution for injection PPA1463/251/003 |
Tinzaparin sodium | IMED Healthcare Ltd., | — |
| Innohep 10,000 IU/ml solution for injection PA0046/060/002 |
Tinzaparin sodium | Leo Laboratories Limited | Marketed |
| Innohep 12,000 IU in 0.6 ml, Solution for injection PA0046/060/013 |
Tinzaparin sodium | Leo Laboratories Limited | Marketed |
| innohep 14,000 IU in 0.7 ml, solution for injection PPA0465/499/004 |
Tinzaparin sodium | PCO Manufacturing Ltd. | — |
| Innohep 14,000 IU in 0.7 ml, solution for injection PA0046/060/011 |
Tinzaparin sodium | Leo Laboratories Limited | Marketed |
| Innohep 14,000 IU in 0.7 ml, solution for injection PPA1463/251/004 |
Tinzaparin sodium | IMED Healthcare Ltd., | — |
| Innohep 16,000 IU in 0.8 ml, Solution for injection PA0046/060/014 |
Tinzaparin sodium | Leo Laboratories Limited | Marketed |
| innohep 18,000 IU in 0.9 ml, solution for injection PPA0465/499/005 |
Tinzaparin sodium | PCO Manufacturing Ltd. | — |
| Innohep 18,000 IU in 0.9 ml, solution for injection PA0046/060/004 |
Tinzaparin sodium | Leo Laboratories Limited | Marketed |
| Innohep 2,500 IU, solution for injection PA0046/060/008 |
Tinzaparin sodium | Leo Laboratories Limited | Marketed |
| Innohep 20,000 IU/ml Solution for Injection PA0046/060/003 |
Tinzaparin sodium | Leo Laboratories Limited | Marketed |
| innohep 3,500 IU, solution for injection PPA0465/499/002 |
Tinzaparin sodium | PCO Manufacturing Ltd. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.